跳至主要内容
临床试验/ITMCTR2022000037
ITMCTR2022000037尚未招募1 期

A study on strategies for the prevention and treatment of metabolic syndrome in Chinese medicine and the preliminary construction of a predictive model for cardiovascular disease risk - a prospective cohort study

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
30 至 80(—)
性别
All

入选标准

  • (1) age 30-80 years, gender not limited;
  • (2) meet the diagnostic criteria for metabolic syndrome and any of the above TCM evidence types;
  • (3) have good compliance;
  • (4) sign the informed consent form.

排除标准

  • (1) Exclusion of other primary diseases causing (chronic kidney disease, chronic liver disease, hypothyroidism) abnormalities in blood glucose, lipids and blood pressure.
  • (2) Combination of severe cardiovascular and cerebrovascular diseases, such as heart failure, severe hypertension, cerebral haemorrhage, etc.
  • (3) Combined with severe liver function abnormalities (ALT or AST reaching more than 3 times the upper limit of normal), endocrine diseases, malignant tumours and autoimmune diseases
  • (4) Women who are pregnant, preparing for pregnancy or breastfeeding.
  • (5) Allergy and hypersensitivity to the components of the drug used in this study.
  • (6) Those who are participating in other clinical trials or have participated in clinical trials of other drugs for less than 1 month.

研究者

相似试验